Together, let's innovate.
Management and Board
Patrick Myles is the Chief Executive Officer of Huron Digital Pathology. Patrick joined Huron in 2014 as Executive Vice President, Business Development. He was promoted to company President in 2015 and became Chief Executive Officer in 2016. He brings to the company 18 years of experience at Teledyne DALSA, an international manufacturer of digital imaging components with $250 million in annual revenue. There, he was responsible for corporate business development, seeking out and evaluating opportunities to drive organic and inorganic growth. Prior to DALSA’s acquisition by Teledyne in 2011, Patrick had responsibility for investor relations, marketing, corporate communications, and served as corporate secretary.
Patrick has a Bachelor of Arts degree from the University of Waterloo and an MBA from Wilfrid Laurier University. He has served as a board member of the United Way Kitchener Waterloo and Area, the University of Waterloo Magazine advisory committee, and the Ontario Chapter of the Canadian Investor Relations Institute.
Audil Virk is the Chief Operating Officer with more than 10 years of progressively responsible experience, having started his career with Huron as the head of software development. In his current role, Audil is responsible for strategic planning and execution, budget planning, staff development, and cost reductions with quality improvements. Audil directs the day-to-day operations, guides product development, and works closely with the sales team.
Prior to Huron, Audil worked in the telecommunications industry for Mitel Networks, where he was an inventor of two software patents on managing log files. He holds a BSc in Biochemistry from Queen’s University and a diploma in Computer Engineering Technology from Saint Lawrence College.
Savvas become Chief Technology Officer for Huron in 2010. He joined the company (originally known as Biomedical Photometrics Inc.) in 1998 as project leader. He led the development and manufacturing of micro array readers, tissue imaging systems, and a MacroScope/Microscope combination system for general confocal imaging applications. He has been involved in the development of imaging systems for more than 20 years and is the author of several patents and more than 30 publications on confocal microscopy imaging techniques and applications.
Savvas Damaskinos received his Ph.D. in Physics from the University of Waterloo in 1985 and was the first recipient of the GWP Pearson medal for graduate work in Physics. He spent three years at the Institute of Energy Conversion in Delaware, a centre of excellence for photovoltaics, returning to the Department of Physics at the University of Waterloo as a Research Associate Professor in 1988. Research activities at the Physics Department resulted in several patents in the area of confocal scanning laser imaging technology.
Savvas Chamberlain a Distinguished Professor Emeritus of the University of Waterloo is presently the CEO and Chairman of EXEL Research Inc. a company which provides services to identify and commercialize innovations arising from university research. This company also invests in promising young high tech companies in Canada.
Savvas was born in Dhikomo, Cyprus, of Greek Cypriot heritage. He was educated in England, received his first degree in London, and his M.Sc. and Ph.D. degrees from Southampton University. After his Ph.D. in 1968 he worked briefly with Plessey Research Laboratories in Caswell, and then immigrated in 1969 to Canada. In 1974 he became a proud Canadian Citizen. In July 2009 Savvas was inducted into the Order of Canada. He is a resident of Ontario. In 1980 he founded DALSA, a successful Semiconductor and Electronics company in Canada.
Mike is President of Pinnacle Capital Partners, a self-funded private equity group. He spends most of his time managing the portfolio of companies, completing acquisitions, and serving on the board of directors of investee companies.
He started his career working in public accounting with Zittrer Siblin Stein Levine (merged with EY in 1988) before joining the Canada Revenue Agency in Kitchener from 1988 to 1999 as a tax auditor and then as a Senior Business Valuator. In 1999 he returned to public accounting for one year before venturing out in 2000 to co-find Pinnacle Capital Partners, offering services in mergers and acquisitions, financings and divestitures.
Mike studied at Wilfrid Laurier University obtaining an Honors Business Administration degree with an option in Economics in 1987. He continued his studies while working, obtaining the designation of Chartered Business Valuator (CBV) in 1997 and Chartered Financial Analyst (CFA), designation in 2001.
Ted is the founder of Biomedical Photometrics Inc., the predecessor to Huron Digital Pathology. He is also Professor Emeritus, Department of Physics and Astronomy, University of Waterloo. He invented Huron’s Moving Specimen Image Averaging (MSIA) technology, and continues to lead Huron’s patent development and application process. He is the inventor or co-inventor of 13 US Patents and several US and International patents pending.
He is a Director of the Centre for Imaging Technology Commercialization (CIMTEC), and was a member (2013) of the Council of Canadian Academies’ Expert Panel on the Socio-economic Impact of Innovation Investments. He has been a member of the Advisory Board of the National Research Council Canada’s Steacie Institute for Molecular Sciences, a Director of DALSA Corp., a Principal Investigator in Photonics Research Ontario, Founder and CEO of Biomedical Photometrics Inc. (now Huron Digital Pathology), and Founder and Chairman of Waterloo Scientific Inc.
At the University of Waterloo, Ted’s research focused on the development and commercial application of scanning laser imaging technology. An early patent supported the founding of Waterloo Scientific in 1983, and the development of additional patented technologies and applications supported the founding of Biomedical Photometrics in 1994.
Ted was awarded the Canadian Association of Physicists / National Optics Institute Medal for Outstanding Achievement in Applied Photonics in 2006.
Christine is Vice-President of Operations at EXEL Research Inc., a company based in Waterloo Ontario that focuses on investment in small high-tech companies and in vacation rental properties management. She began working with EXEL in May 2004, as Director of Operations.
Previously, Christine was Manager of Undergraduate Processing at the Ontario Universities Application Centre (OUAC) in Guelph, Ontario. She began her career in 1981 at Wilfrid Laurier University in the Office of the Registrar, beginning as Admissions Officer and ultimately being becoming Assistant Registrar, Admissions prior to leaving Laurier in 1996.
She holds a Bachelor of Music degree from Wilfrid Laurier University and has completed a number of courses at Laurier’s School of Business and Economics. Christine is a member of the Board of Directors and Secretary of the Savvas Chamberlain Family Foundation www.scffoundation.com , a past member of the board of directors of the Kitchener-Waterloo Symphony (KWS), a current a member of the Wilfrid Laurier University President’s Regional Council of Advisors, and a member of the President’s Advisory Council of the KWS.
Advisory Board Members
Arthur Carty, Advisory Board Chair. Inaugural Executive Director and Senior Fellow, Waterloo Institute for Nanotechnology, University of Waterloo
Victor Tron, Chief, Laboratory Medicine, St. Michael’s Hospital, Toronto
Suzee Camilleri, Director CMHD Pathology Core, Toronto Centre for Phenogenomics, Mount Sinai Hospital, Toronto
Brian Doody, Chief Executive Officer (retired), Teledyne DALSA
Hamid Tizhoosh, Professor, Director of KIMIA Lab, University of Waterloo
Launch 2nd generation TissueScope LE, optimized for faster scanning
Receive Frost & Sullivan’s 2013 Product Excellence Award in Slide Scanners
Launch TissueScope HS Scanner and TissueView software
TissueScope awarded 1st prize in two categories (20X Fluorescence and 40X Fluorescence) at the 2nd International Scanner Contest
Launch TissueScope Autoloader for continuous operation and automated workflow
Receive injection of new capital from investors Savvas Chamberlain and Mike Panayi. Company name changed from Biomedical Photometrics Inc. to Huron Technologies Inc.
Next generation TissueScope scanner for whole mount breast imaging at Sunnybrook hospital
Introduce 1st generation TissueScope multi-slide holder scanner for brightfield and fluorescence imaging of microscope slides
Launch first TissueScope scanner for brightfield and fluorescence imaging of microscope slides
Introduce 3rd generation DNAscope scanner for DNA microarrays
Launch 2nd generation DNAscope scanner for DNA microarrays
Develop first DNAscope scanner for DNA microarrays
Biomedical Photometrics Inc. founded to commercialize scanning laser imaging technology developed at the University of Waterloo.